Caroline M. Robb

571 total citations
17 papers, 405 citations indexed

About

Caroline M. Robb is a scholar working on Oncology, Molecular Biology and Sociology and Political Science. According to data from OpenAlex, Caroline M. Robb has authored 17 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Sociology and Political Science. Recurrent topics in Caroline M. Robb's work include Cancer-related Molecular Pathways (4 papers), Income, Poverty, and Inequality (3 papers) and Poverty, Education, and Child Welfare (3 papers). Caroline M. Robb is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Income, Poverty, and Inequality (3 papers) and Poverty, Education, and Child Welfare (3 papers). Caroline M. Robb collaborates with scholars based in United States. Caroline M. Robb's co-authors include Jacob I. Contreras, Smit Kour, Yogesh A. Sonawane, Amarnath Natarajan, Sandeep Rana, Margaret Taylor, Muhammad Zahid, Mohammad Abid, Daryl J. Murry and Sanjib Chowdhury and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Caroline M. Robb

15 papers receiving 367 citations

Peers

Caroline M. Robb
Yi-Ting Wang Taiwan
John R. Wells United States
William H. Meyer United States
Sungmi Song Luxembourg
Richard J. Jones United Kingdom
Rebecca Wolfe United States
N. Stern Israel
Jennifer Peresie United States
Michael Burton United States
Elias Jabbour Brazil
Yi-Ting Wang Taiwan
Caroline M. Robb
Citations per year, relative to Caroline M. Robb Caroline M. Robb (= 1×) peers Yi-Ting Wang

Countries citing papers authored by Caroline M. Robb

Since Specialization
Citations

This map shows the geographic impact of Caroline M. Robb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline M. Robb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline M. Robb more than expected).

Fields of papers citing papers by Caroline M. Robb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline M. Robb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline M. Robb. The network helps show where Caroline M. Robb may publish in the future.

Co-authorship network of co-authors of Caroline M. Robb

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline M. Robb. A scholar is included among the top collaborators of Caroline M. Robb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline M. Robb. Caroline M. Robb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Crimmins, Gregory, et al.. (2024). Synergistic effects of RPT1G, a first-in-class small molecule NAMPT inhibitor, with venetoclax and olaparib in hematological malignancies.. Journal of Clinical Oncology. 42(16_suppl). e18512–e18512.
2.
Crimmins, Gregory, et al.. (2023). RPT1G: A 1 st-in-Class Small Molecule NAMPT Inhibitor As a Novel Therapeutic for Acute Lymphocytic Leukemia. Blood. 142(Supplement 1). 419–419.
3.
Rana, Sandeep, Smit Kour, Yogesh A. Sonawane, et al.. (2020). Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK. Chemical Biology & Drug Design. 96(2). 773–784. 13 indexed citations
4.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2020). Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11(25). 2462–2463. 3 indexed citations
5.
Kour, Smit, Sandeep Rana, Jacob I. Contreras, et al.. (2019). CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Molecular Pharmacology. 96(4). 419–429. 21 indexed citations
6.
Robb, Caroline M., Jacob I. Contreras, Smit Kour, et al.. (2017). Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical Communications. 53(54). 7577–7580. 177 indexed citations
7.
Agarwal, Ekta, et al.. (2017). Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis. Oncogene. 36(22). 3104–3118. 34 indexed citations
8.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2017). Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9(4). 5216–5232. 25 indexed citations
9.
Robb, Caroline M.. (2015). Abstract 3088: Inhibition of CDK5 in colorectal cancer. Cancer Research. 75(15_Supplement). 3088–3088. 1 indexed citations
10.
Park, Hyewon, et al.. (2014). Ewing sarcoma EWS protein regulates midzone formation by recruiting Aurora B kinase to the midzone. Cell Cycle. 13(15). 2391–2399. 15 indexed citations
11.
Robb, Caroline M.. (2013). Changing Power Relations in the History of Aid. 39–59. 6 indexed citations
12.
13.
Robb, Caroline M., et al.. (2003). Poverty and Social Impact Analysis: Linking Macroeconomic Policies to Poverty Outcomes: Summary of Early Experiences. IMF Working Paper. 3(43). 1–1. 3 indexed citations
14.
Robb, Caroline M.. (2000). How the poor can have a voice in government policy.. Finance & development. 37(4). 22–25. 12 indexed citations
15.
Robb, Caroline M.. (1999). Can the Poor Influence Policy?: Participatory Poverty Assessments in the Developing World. 75 indexed citations
16.
Robb, Caroline M.. (1998). Can the poor influence policy?. The World Bank eBooks. 7 indexed citations
17.
Robb, Caroline M., et al.. (1998). 8. PPAs: a review of the World Bank’s experience; Some Reflections on the PPA Process and Lessons Learned. Practical Action Publishing eBooks. 131–146. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi-Ting Wang Breakdown of academic impact, for papers by John R. Wells Breakdown of academic impact, for papers by William H. Meyer Breakdown of academic impact, for papers by Sungmi Song Breakdown of academic impact, for papers by Richard J. Jones Breakdown of academic impact, for papers by Rebecca Wolfe Breakdown of academic impact, for papers by N. Stern Breakdown of academic impact, for papers by Jennifer Peresie Breakdown of academic impact, for papers by Michael Burton Breakdown of academic impact, for papers by Elias Jabbour
Rankless by CCL
2026